These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 39011636)

  • 1. Cardiovascular risk associated with changes in anticholinergic load on four different scales: a registry-based cohort study of geriatric outpatients.
    Riis J; Kragholm K; Søndergaard MM; Clemmensen S; Hansen LT; Torp-Pedersen C; Melgaard D
    Age Ageing; 2024 Jul; 53(7):. PubMed ID: 39011636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing Risks of Polypharmacy Involving Medications With Anticholinergic Properties.
    Hanlon P; Quinn TJ; Gallacher KI; Myint PK; Jani BD; Nicholl BI; Lowrie R; Soiza RL; Neal SR; Lee D; Mair FS
    Ann Fam Med; 2020 Mar; 18(2):148-155. PubMed ID: 32152019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Nine Instruments to Calculate Anticholinergic Load in a Large Cohort of Older Outpatients: Association with Cognitive and Functional Decline, Falls, and Use of Laxatives.
    Mayer T; Meid AD; Saum KU; Brenner H; Schöttker B; Seidling HM; Haefeli WE
    Am J Geriatr Psychiatry; 2017 May; 25(5):531-540. PubMed ID: 28233606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between using medications with anticholinergic properties and short-term cognitive decline among older men: A retrospective cohort study in Taiwan.
    Wu YH; Wang CJ; Hung CH; Chen LY; Lin MH; Wang PN; Chen LK
    Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():57-64. PubMed ID: 28436193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of aspiration pneumonia using the Anticholinergic Risk Scale.
    Kose E; Hirai T; Seki T
    Geriatr Gerontol Int; 2018 Aug; 18(8):1230-1235. PubMed ID: 29856113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-Year Evaluation of a Targeted Medication Therapy Management Intervention for Older Adults.
    Martinez AI; Abner EL; Jicha GA; Rigsby DN; Eckmann LC; Huffmyer MJ; Moga DC
    J Manag Care Spec Pharm; 2020 Apr; 26(4):520-528. PubMed ID: 32223601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the association of anticholinergic burden with depression in older adults: a cross-sectional study.
    Kayahan Satış N; Naharcı Mİ
    Psychogeriatrics; 2024 May; 24(3):597-604. PubMed ID: 38484758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total anticholinergic burden and risk of mortality and cardiovascular disease over 10 years in 21,636 middle-aged and older men and women of EPIC-Norfolk prospective population study.
    Myint PK; Fox C; Kwok CS; Luben RN; Wareham NJ; Khaw KT
    Age Ageing; 2015 Mar; 44(2):219-25. PubMed ID: 25430550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictive value of anticholinergic drug exposure and the outcome of pneumonia: a Danish database study.
    Yoshimatsu Y; Kragholm K; Clemmensen SZ; Melgaard D; Torp-Pedersen C; Smithard DG; Riis J
    Age Ageing; 2024 Feb; 53(2):. PubMed ID: 38337045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation Between Delirium and Anticholinergic Drug Burden in a Cohort of Hospitalized Older Patients: An Observational Study.
    Pasina L; Colzani L; Cortesi L; Tettamanti M; Zambon A; Nobili A; Mazzone A; Mazzola P; Annoni G; Bellelli G
    Drugs Aging; 2019 Jan; 36(1):85-91. PubMed ID: 30484239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticholinergic load negatively correlates with recovery of cognitive activities of daily living for geriatric patients after stroke in the convalescent stage.
    Kose E; Hirai T; Seki T; Hidaka S; Hamamoto T
    J Clin Pharm Ther; 2018 Dec; 43(6):799-806. PubMed ID: 29770467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticholinergic Burden and Functional Status in Older People with Cognitive Impairment: Results from the Regal Project.
    Boccardi V; Baroni M; Paolacci L; Ercolani S; Longo A; Giordano M; Ruggiero C; Mecocci P
    J Nutr Health Aging; 2017; 21(4):389-396. PubMed ID: 28346565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticholinergic drugs use and risk of hip fracture in geriatric patients.
    Kose E; Hirai T; Seki T
    Geriatr Gerontol Int; 2018 Sep; 18(9):1340-1344. PubMed ID: 30044045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of anticholinergic burden in elderly outpatients and the risk factors.
    Lu X; Huang H; Huang Y; Zhang L; Wu X; Wang Z; Xiao J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 48(1):114-122. PubMed ID: 36935184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, risk factors and adverse outcomes of anticholinergic burden in patients with advanced chronic conditions at hospital admission.
    Sevilla-Sánchez D; Molist-Brunet N; González-Bueno J; Solà-Bonada N; Espaulella-Panicot J; Codina-Jané C
    Geriatr Gerontol Int; 2018 Aug; 18(8):1159-1165. PubMed ID: 29644803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticholinergic Burden and Cognitive Impairment in Nursing Homes: A Comparison of Four Anticholinergic Scales.
    Novella A; Elli C; Ianes A; Pasina L
    Drugs Aging; 2023 Nov; 40(11):1017-1026. PubMed ID: 37620654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of comprehensive geriatric assessment on anticholinergic exposure assessed by four ranked anticholinergic lists.
    Lampela P; Taipale H; Lavikainen P; Hartikainen S
    Arch Gerontol Geriatr; 2017; 68():195-201. PubMed ID: 27837709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticholinergic Medication Burden in Parkinson's Disease Outpatients.
    Nawaz H; Sargent L; Quilon H; Cloud LJ; Testa CM; Snider JD; Lageman SK; Baron MS; Berman BD; Zimmerman K; Price ET; Mukhopadhyay ND; Barrett MJ
    J Parkinsons Dis; 2022; 12(2):599-606. PubMed ID: 34806617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study.
    Pasina L; Djade CD; Lucca U; Nobili A; Tettamanti M; Franchi C; Salerno F; Corrao S; Marengoni A; Iorio A; Marcucci M; Violi F; Mannucci PM
    Drugs Aging; 2013 Feb; 30(2):103-12. PubMed ID: 23239364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome.
    Taylor-Rowan M; Edwards S; Noel-Storr AH; McCleery J; Myint PK; Soiza R; Stewart C; Loke YK; Quinn TJ
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013540. PubMed ID: 34097766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.